{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"technology_type":["Illumina HT12.4"],"study_type":["Other"],"full_dataset_link":["https://ega-archive.org/studies/EGAS00001002922"],"host":["EGA"],"description":["EGA study EGAS00001002922"],"dataset_title":["Raw mRNA expressions","Normalised mRNA expressions"],"category":["restricted"],"repository":["EGA"],"name_synonyms":["melanoma (disease), Melanomas, Melanoma, Gene Expressions, melanoma, malignant, Malignant Melanoma, Naevocarcinoma, malignant melanoma, study., Gene, Expression, Malignant Melanomas, Malignant, Expressions"],"description_synonyms":["School-Age Populations, study, Populations, data, malignant, long, Naevocarcinoma, follow up, whole genome, Malignant Melanomas, Population, Malignant, School Age Populations, DOI, doi., Impact, Environmental Impact, Environmental, School-Age, melanoma (disease), Melanomas, Melanoma, 10^[-6], melanoma, School Age, Malignant Melanoma, Environments, microarray, Impacts, 2018, malignant melanoma, School-Age Population, School Age Population, Environmental Impacts, other neoplasm"],"additional_accession":[]},"is_claimable":false,"name":"Leeds Melanoma Cohort (LMC) gene expression study","description":"Array-based profiling (whole genome DASL HT12.4, Illumina Inc) in over 700 FFPE tumour blocks from the population-based Leeds Melanoma cohort recruited in the North of England, with a long follow up.\nData used in tumour immune micro-environment investigation (Nsengimana et al 2018, J Clin Invest  doi: 10.1172/JCI95351).","dates":{"updated":"2018-05-15 15:51:03"},"accession":"EGAS00001002922","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAD00010001562","EGAD00010001561","EGAC00001000893"]}}